Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$23.2B
111M shares
52-week range
$164.65 – $214.21
95% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NYSE
CS
Borrow rate
0.33%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.53B | $7.73B | $9.44B | $10.79B | $9.88B | $9.25B | $9.87B | $11.04B |
| Cost of revenue | $4.93B | $5.04B | $5.80B | $6.58B | $6.45B | $6.20B | $6.63B | $7.51B |
| Gross profit | $2.60B | $2.69B | $3.63B | $4.21B | $3.43B | $3.07B | $3.24B | $3.52B |
| Gross margin | 34.6% | 34.8% | 38.5% | 39.0% | 34.7% | 33.2% | 32.9% | 31.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.10B | $1.23B | $1.97B | $2.38B | $1.43B | $1.26B | $1.35B | $1.60B |
| EBITDA | $1.40B | $1.58B | $2.41B | $3.16B | $1.82B | $1.73B | $1.89B | $2.19B |
| Net income | $736.0M | $858.0M | $1.43B | $2.00B | $946.0M | $854.0M | $871.0M | $992.0M |
| Net margin | 9.8% | 11.1% | 15.2% | 18.5% | 9.6% | 9.2% | 8.8% | 9.0% |
| EPS (diluted) | 5.29 | 6.29 | 10.52 | 15.53 | 7.98 | 7.52 | 7.69 | 8.75 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $11.9B | $10.75 | $10.58–$10.85 | 12 |
| 2027 | $12.4B | $11.67 | $11.43–$12.05 | 12 |
| 2028 | $12.9B | $12.73 | $12.02–$13.52 | 7 |
| 2029 | $13.7B | $14.26 | $14.07–$14.48 | 2 |
Forward consensus · source: Financial Modeling Prep
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
www.questdiagnostics.comNo one on the platform currently holds DGX.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-09-30 | 38,100 | $5.9M |
| Bridgewater Associatesas of 2026-03-31 | 3,471 | $680.2K |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-08 | $0.8600 | 2026-07-22 |
| 2026-04-06 | $0.8600 | 2026-04-20 |
| 2026-01-13 | $0.8000 | 2026-01-28 |
| 2025-10-03 | $0.8000 | 2025-10-20 |
| 2025-07-07 | $0.8000 | 2025-07-21 |
| 2025-04-07 | $0.8000 | 2025-04-21 |
| 2025-01-14 | $0.7500 | 2025-01-29 |
| 2024-10-04 | $0.7500 | 2024-10-21 |
| 2024-07-08 | $0.7500 | 2024-07-22 |
| 2024-04-05 | $0.7500 | 2024-04-22 |
No one on the platform has traded DGX yet.
| $22.9B |
| — |
| MEDPMedpace Holdings, Inc. | $534.72 | +1.45% | $15.3B | — |
| THCTenet Healthcare Corporation | $187.17 | -0.97% | $16.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2024-01-16 |
| $0.7100 |
| 2024-01-31 |
| 2023-10-05 | $0.7100 | 2023-10-23 |
| Execution date | Ratio |
|---|---|
| 2005-06-21 | 2-for-1 |
Trading at 26.8× earnings vs its 18.1× historical median P/E.
Fair value ≈ $143.63 · price $211.95 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$DGX just had a cancer scare with my wife. We are the lucky ones but the experience was devastating. Brutal waiting. What it does to your mind, the worst. To be invested in a company improving testing in any way brings me pride more now than it did a couple weeks ago. My heart will never forget those going through this. Keep up the good work $DGX
View on StockTwits ↗$DGX Current Stock Price: $203.11 Contracts to trade: $200.0 DGX Jul 17 2026 Call Entry: $6.30 Exit: $8.37 ROI: 33% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$DGX https://newsroom.questdiagnostics.com/2026-06-24-Quest-Diagnostics-Receives-New-York-State-Approval-for-Haystack-MRD-R-,-Broadening-Patient-Access-to-ctDNA-Minimal-Residual-Disease-Testing FYI NY state approves use of Haystack test for ctDNA blood test for cancer monitoring
View on StockTwits ↗$DGX got a starter here and at $NOW . Lets see where this goes
View on StockTwits ↗$DGXX from Gerard Rotonda Board Director of DGXX: There are moments when a company emerges from becoming something into undeniably being something. DigiPowerX has emerged. I serve as a Director of $DGXX and these are my personal views, not the Company's. Everything here comes from public filings and press releases. This is not investment advice. What follows is my perspective as a Board Member, grounded entirely in publicly disclosed information. I've been in the rooms. I've sat across from Michel Amar in strategy sessions, attended investor meetings, reviewed the financial models, and watched this executive team: Alec, Jag, Paul, and others, supported by expert legal counsel and senior leaders of the world's largest financial institutions, make decisions under real pressure with real capital on the line. What I'm about to share is my personal view, grounded in publicly disclosed information, because I think the magnitude of what is being built here deserves to be said clearly. THE FUTURE OF AI IS PHYSICAL Many talk about AI as if it lives in the cloud. It doesn't. It lives in buildings. Buildings that require hundreds of megawatts of power, purpose-built cooling systems, owned land, Tier III infrastructure, and teams who know how to operate it at scale without blinking. We are at the beginning of what will be the largest infrastructure buildout in human history. Not the largest tech buildout. The largest infrastructure buildout - period. The demand for AI compute is doubling and doubling again. The models are getting larger. The inference requirements are exploding. OpenAI, Google, Meta, Amazon, and every major enterprise on earth is racing to deploy AI at scale and every single one of them needs power and physical compute infrastructure to do it. The companies that secured that infrastructure early, before the utilities ran out of capacity, before the land was gone, before the power agreements became impossible to sign - are sitting on assets that cannot be replicated at any price today. DigiPowerX is one of those companies. THE PICTURE I'M POSTING That photo is a Cerebras data center, 10 MW of operational AI compute. Take a look at it. Quiet on the outside. Inside: wafer-scale AI chips, liquid cooling running nonstop, redundant power, and some of the most powerful AI inference hardware ever deployed. This is what the physical layer of the AI revolution looks like. DigiPowerX is building four times this, 40 MW. On land we own in Columbiana, Alabama. Powered by a substation we built. Backed by 393 MW of secured power across our portfolio. And anchored by a $1.1 billion, 10-year Master Services Agreement with Cerebras, the company that operates that exact facility in the photo. Phase 1 - 15 MW - comes online December 15, 2026. Full 40 MW delivered by Q1 2027. Substation: complete. Grid interconnection: finalized. All long-lead equipment: secured. MICHEL AMAR AND WHAT I'VE SEEN FROM THE INSIDE I've reviewed the financial models. I've been in the investor meetings. I've walked, almost running to keep up, with Michel through back-to-back meetings, building to building across midtown Manhattan. It actually was a very productive and exciting day. I've watched Michel Amar operate, and I want to say publicly what I believe privately: he and Alec saw this coming before many in this space did. We have meetings 24/7, including Saturday's and Sunday's. Many mornings I wake up and there is already a new text or email from Michel on something to be discussed after I grab a large cup of coffee. They made the call to walk away from Bitcoin mining before it was obvious. They secured the power before it became scarce. We signed Cerebras - one of the most consequential AI compute companies in the world - before breaking ground on the data center. They built NeoCloudz and launched GPU-as-a-Service while the flagship campus was still under construction. And he did all of this with a balance sheet that today carries approximately $150 million in cash and zero long-term debt. That is not luck. That is vision, executed with discipline. Cerebras, for context, just completed the largest IPO of 2026 on Nasdaq (CBRS) - opening 68% above offering price, raising $5.55 billion, holding a $20B+ relationship with OpenAI. They looked at every option available to them and chose DigiPowerX to be included. A billion-dollar bet on our team and the assets we've assembled. I've seen the plan from the inside. What's being communicated publicly reflects exactly what I've seen in execution. There is no gap. WHERE THIS IS GOING The AI data center of the future isn't a retrofitted warehouse. It's purpose-built from the ground up - for liquid-cooled, 150kW+ rack density, Tier III uptime, and the kind of power reliability that frontier AI demands. It sits on owned land, connected to grid power that was secured years ago, and operated by people who've never run anything less. That is exactly what DigiPowerX is building. And we're not stopping at 40 MW. The pipeline includes a 1.3 GW Letter of Intent in West Virginia - targeted for 2028 through 2030. As AI scales from tens of megawatts to gigawatts, DigiPowerX is already positioned for that next phase. NeoCloudz, our GPU-as-a-Service platform, is live right now on NVIDIA B200 and B300 bare metal - the fastest, most powerful AI compute available today. First revenues recognized in May 2026. And we've already committed $35 million to NVIDIA's Vera Rubin platform - the successor to Blackwell - for Q1 2027 deployment. We try to be one generation ahead. Project financing is advancing with one of the world's largest private credit institutions - managing $220B+ in credit assets - structured as non-dilutive 70/30 debt. Firms at this level don't commit to a process without exhaustive underwriting. The fact that this financing is moving forward is itself a validation: of the asset quality, the contracted cash flows, and the professionalism of the DigiPowerX team in every aspect of how this company conducts its business affairs. THE NUMBERS - PUBLICLY STATED MANAGEMENT TARGETS 2026 → First AI revenues. NeoCloudz live. SubQ AI 24-month bare metal contract (~$19.6M). Revenue engine started. 2027 → ~$300M revenue run rate. Full 40 MW Cerebras campus online. NeoCloudz scaling. 2028 → $450–$500M run rate. 2029 → $800M–$1B run rate. These are Michel's publicly stated targets. Subject to all the risks in our public filings. But they are grounded in assets that already exist, contracts that are already signed, and a team that is already executing. I'm proud to serve on this board. I'm proud of Michel Amar, Alec Amar, Paul Ciullo, Jagan Jeyapaul, and every person building this platform. And I'm proud of what this company represents for the future of AI infrastructure in America. The AI revolution needs a physical layer. DigiPowerX is building it. That photo shows 10 MW. - We're delivering 40 MW. - And we're just getting started. Full press release (June 3, 2026): http://digipowerx.com/press-releases Gerard Rotonda | Director, DigiPowerX Inc. $DGXX $DGX #DigiPowerX #AIInfrastructure #DataCenter #GPUaaS #NeoCloudz #NVIDIA #Cerebras #AICompute #FutureOfAI #PowerInfrastructure #NasdaqStocks
$AMT $DGX $PLTR $RACE Wow, this genie lamp I picked up on $EBAY actually had a few wishes left; interesting. Aside from DGX, it’s the forward P/E that still has me hesitant. Genie oh Genie, the greatest in the land, please come out of your lamp and…..
View on StockTwits ↗$DGX starting a position here as the 200 days moving average has been a solid support area.
View on StockTwits ↗$AMT $DGX All you have to do is ask nicely; some of y’all need to check your karma. While we’re at it; how about $PLTR at….
View on StockTwits ↗Doing a little reshuffling to rebalance the port with quality names to offset high beta names. Wouldn’t mind adding $AMT and $DGX if we get a little pullback.
View on StockTwits ↗$DGX AI health analysis market… that’s all you need to know. Could see a super growth cycle
View on StockTwits ↗$DGX guess I’m buy happy today. Added to my $HIMS position. Started in $CELH after a good long pullback, now I’m starting a position here. Got a hunch medical testing is gonna start showing up on radars and I like where this is. Maybe I’m wrong? Can’t make money sitting out.
View on StockTwits ↗$DGX Current Stock Price: $189.15 Contracts to trade: $190.0 DGX May 15 2026 Call Entry: $2.00 Exit: $3.28 ROI: 64% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.